CAS: 59214-70-9; 3-Bromobenzofuran

上下游产品

CAS号109210-15-3 2,3-dibromo-2,3... | CAS号64150-61-4 2,3-二溴苯并呋喃 | CAS号58863-52-8 trans-2,3-dibro... | CAS号86324-77-8 trans-3-bromo-2... | CAS号86324-78-9 trans-3-bromo-2... | CAS号68051-08-1 trans-2,3-Dibro... | CAS号271-89-6 苯并呋喃 | CAS号496-41-3 苯并[b]呋喃-2-羧酸 | CAS号5101-44-0 2-乙炔基苯酚 | CAS号26537-68-8 苯并呋喃-3-羧酸 | CAS号796851-30-4 3-(4,4,5,5-四甲基-... | CAS号271-89-6 苯并呋喃 | CAS号99661-02-6 1-(3-溴-1-苯并呋喃-2... | CAS号7169-34-8 3-氯杀鼠灵酮 | CAS号66611-15-2 3-乙酰基苯并[b]呋喃 | CAS号33224-99-6 2-ethoxy-2-phen... | CAS号614-75-5 邻羟基苯乙酸

2,3-苯并呋喃置于溴,Potassium Hydroxide体系中,用 二氯甲烷,乙醇 作为反应溶剂,化学反应 5.0H,以45%的收率获得产物3-溴-1-苯并呋喃
参考文献:Triple Oxa[7] Helicene 与圆偏振发光:通过 Helicene 亚基倍增增强不对称因子
标题:Triple Oxa[7] Helicene 与圆偏振发光:通过 Helicene 亚基倍增增强不对称因子
摘要:具有高发光不对称因子(g Lum)的多个异螺旋烯的开发是一项有吸引力但具有挑战性的任务.在此,我们公开了一种结构不寻常的基于呋喃的三重氧杂 [7] 螺旋烯,它是第一个报道的三重杂 [7] 螺旋烯,通过 [2+2+2] 环三聚化/分子内脱氢环化.与报道的双氧杂[7]螺旋相比,三氧杂[7]螺旋的g Lum值提高了1.8 x 10-3,证明了螺旋亚基倍增方法在增强异螺旋的g Lum方面的潜力.
DOI:10.1021/acs.Orglett.1C01212

专利信息

专利号:US-10508092-B2
优先权日:2016-09-02
标题 :Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them
发明人：XU WEI; TANG WEIPING; LIU JITIAN; KOLESAR JILL
权利人:WISCONSIN ALUMNI RES FOUND
摘要:Disclosed are unnatural analogs of Diptoindonesin G, methods to make the analogs, pharmaceutical compositions containing the analogs, and methods of using the analogs to inhibit neoplastic cell growth.

专利号:US-2018065945-A1
优先权日:2016-09-02
标 题 :Synthesis of novel analogs of diptoindonesin g, compounds formed thereby, and pharmaceutical compositions containing them

专利号:US-10150111-B2
优先权日:2016-09-06
标题 :Method for catalytic synthesis of cinnamic acid with catalyst recycle

专利号:US-2018326410-A1
优先权日:2016-09-06
标题 :Method for catalytic synthesis of cinnamic acid with catalyst recycle

专利号:US-4454320-A
优先权日:1980-07-28
标题 :Process for 5-substituted dialuric acids
发明人：RAJECKAS FAUSTAS J; HOLLAND GERALD F
权利人:PFIZER
摘要:A process for the preparation of certain 5-substituted dialuric acids, compounds having utility as intermediates for the synthesis of certan hypoglycemic 5-substituted oxazolidine-2,4-diones.